Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study

Abstract Objective To investigate the impact of patent foramen ovale (PFO) on the short-term outcomes of living donor liver transplantation (LDLT) in children with biliary atresia. Methods With the approval of the hospital ethics committee, 304 children with biliary atresia who underwent LDLT in our...

Full description

Bibliographic Details
Main Authors: Yuli Wu, Yongle Jing, Tianying Li, Lu Che, Mingwei Sheng, Lili Jia, Hongxia Li, Wenli Yu, Yiqi Weng
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-023-02268-w
_version_ 1797556899036528640
author Yuli Wu
Yongle Jing
Tianying Li
Lu Che
Mingwei Sheng
Lili Jia
Hongxia Li
Wenli Yu
Yiqi Weng
author_facet Yuli Wu
Yongle Jing
Tianying Li
Lu Che
Mingwei Sheng
Lili Jia
Hongxia Li
Wenli Yu
Yiqi Weng
author_sort Yuli Wu
collection DOAJ
description Abstract Objective To investigate the impact of patent foramen ovale (PFO) on the short-term outcomes of living donor liver transplantation (LDLT) in children with biliary atresia. Methods With the approval of the hospital ethics committee, 304 children with biliary atresia who underwent LDLT in our center from January 2020 to December 2021 were enrolled. According to the results of echocardiography before the operation, the subjects were divided into the PFO group (n = 73) and the NoPFO group (n = 231). The baseline characteristics; intraoperative recipient-related data and donor-related data; incidence of postreperfusion syndrome (PRS); postoperative mechanical ventilation time; ICU stay duration; postoperative hospital stay duration; liver function index; incidences of postoperative complications including acute renal injury (AKI), graft dysfunction, hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT); and one-year survival rate were compared between the two groups. Results The median age in the PFO group was 6 months and that in the NoPFO group was 9 months (P < 0.001), and the median height (65 cm) and weight (6.5 kg) in the PFO group were significantly lower than those in the NoPFO group (68 cm, 8.0 kg) (P < 0.001). The preoperative total bilirubin level (247 vs. 202 umol/L, P = 0.007) and pediatric end-stage liver disease (PELD) score (21 vs. 16, P = 0.001) in the PFO group were higher than those in the NoPFO group. There were no significant differences in the intraoperative PRS incidence (46.6% vs. 42.4%, P = 0.533 ), postoperative mechanical ventilation time (184 vs. 220 min, P = 0.533), ICU stay duration (3.0 vs. 2.5 d, P = 0.267), postoperative hospital stay duration (22 vs. 21 d, P = 0.138), AKI incidence (19.2% vs. 24.7%, P = 0.333), graft dysfunction incidence (11.0% vs. 12.6%, P = 0.716), HAT incidence (5.5% vs. 4.8%, P = 0.762), PVT incidence (2.7% vs. 2.2%, P = 0.675) or one-year survival rate (94.5% vs. 95.7%, P = 0.929) between the two groups. Conclusion The presence of PFO has no negative impact on short-term outcomes in children with biliary atresia after LDLT.
first_indexed 2024-03-10T17:09:36Z
format Article
id doaj.art-102dc291f1324a15b785f5cd6f24d7ab
institution Directory Open Access Journal
issn 1471-2253
language English
last_indexed 2024-03-10T17:09:36Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj.art-102dc291f1324a15b785f5cd6f24d7ab2023-11-20T10:42:18ZengBMCBMC Anesthesiology1471-22532023-09-012311710.1186/s12871-023-02268-wImpact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort studyYuli Wu0Yongle Jing1Tianying Li2Lu Che3Mingwei Sheng4Lili Jia5Hongxia Li6Wenli Yu7Yiqi Weng8Department of Anesthesiology, Tianjin First Central HospitalDepartment of Cardiology, Tianjin First Central HospitalSchool of Medicine, Nankai UniversityDepartment of Anesthesiology, Tianjin First Central HospitalDepartment of Anesthesiology, Tianjin First Central HospitalDepartment of Anesthesiology, Tianjin First Central HospitalDepartment of Anesthesiology, Tianjin First Central HospitalDepartment of Anesthesiology, Tianjin First Central HospitalDepartment of Anesthesiology, Tianjin First Central HospitalAbstract Objective To investigate the impact of patent foramen ovale (PFO) on the short-term outcomes of living donor liver transplantation (LDLT) in children with biliary atresia. Methods With the approval of the hospital ethics committee, 304 children with biliary atresia who underwent LDLT in our center from January 2020 to December 2021 were enrolled. According to the results of echocardiography before the operation, the subjects were divided into the PFO group (n = 73) and the NoPFO group (n = 231). The baseline characteristics; intraoperative recipient-related data and donor-related data; incidence of postreperfusion syndrome (PRS); postoperative mechanical ventilation time; ICU stay duration; postoperative hospital stay duration; liver function index; incidences of postoperative complications including acute renal injury (AKI), graft dysfunction, hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT); and one-year survival rate were compared between the two groups. Results The median age in the PFO group was 6 months and that in the NoPFO group was 9 months (P < 0.001), and the median height (65 cm) and weight (6.5 kg) in the PFO group were significantly lower than those in the NoPFO group (68 cm, 8.0 kg) (P < 0.001). The preoperative total bilirubin level (247 vs. 202 umol/L, P = 0.007) and pediatric end-stage liver disease (PELD) score (21 vs. 16, P = 0.001) in the PFO group were higher than those in the NoPFO group. There were no significant differences in the intraoperative PRS incidence (46.6% vs. 42.4%, P = 0.533 ), postoperative mechanical ventilation time (184 vs. 220 min, P = 0.533), ICU stay duration (3.0 vs. 2.5 d, P = 0.267), postoperative hospital stay duration (22 vs. 21 d, P = 0.138), AKI incidence (19.2% vs. 24.7%, P = 0.333), graft dysfunction incidence (11.0% vs. 12.6%, P = 0.716), HAT incidence (5.5% vs. 4.8%, P = 0.762), PVT incidence (2.7% vs. 2.2%, P = 0.675) or one-year survival rate (94.5% vs. 95.7%, P = 0.929) between the two groups. Conclusion The presence of PFO has no negative impact on short-term outcomes in children with biliary atresia after LDLT.https://doi.org/10.1186/s12871-023-02268-wPatent foramen ovaleLiving donor liver transplantationBiliary atresiaComplication
spellingShingle Yuli Wu
Yongle Jing
Tianying Li
Lu Che
Mingwei Sheng
Lili Jia
Hongxia Li
Wenli Yu
Yiqi Weng
Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
BMC Anesthesiology
Patent foramen ovale
Living donor liver transplantation
Biliary atresia
Complication
title Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
title_full Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
title_fullStr Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
title_full_unstemmed Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
title_short Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study
title_sort impact of patent foramen ovale on short term outcomes in children with biliary atresia undergoing living donor liver transplantation a retrospective cohort study
topic Patent foramen ovale
Living donor liver transplantation
Biliary atresia
Complication
url https://doi.org/10.1186/s12871-023-02268-w
work_keys_str_mv AT yuliwu impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT yonglejing impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT tianyingli impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT luche impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT mingweisheng impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT lilijia impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT hongxiali impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT wenliyu impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy
AT yiqiweng impactofpatentforamenovaleonshorttermoutcomesinchildrenwithbiliaryatresiaundergoinglivingdonorlivertransplantationaretrospectivecohortstudy